Welcome to our dedicated page for Nakamoto SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Kindly MD, Inc. (NAKA) SEC filings page provides access to the company’s official regulatory disclosures as a publicly traded issuer. KindlyMD, a patient-first and healthcare data company with integrated healthcare services and a Bitcoin treasury strategy via its subsidiary Nakamoto Holdings Inc., uses filings with the U.S. Securities and Exchange Commission to report material events, corporate actions, and financial information.
Among the key documents available are Current Reports on Form 8-K, which the company uses to disclose significant developments. Recent 8-K filings have addressed topics such as the completion of the merger with Nakamoto, entry into and termination of material loan agreements secured by Bitcoin or other digital assets, authorization of a share repurchase program, receipt of a Nasdaq minimum bid price notice, and the establishment of dates and record dates for annual shareholder meetings. These filings also cover matters like redemption of a secured convertible debenture and the company’s financing arrangements with lenders focused on digital assets.
Investors can also review proxy materials, including the Definitive Proxy Statement on Schedule 14A, which outlines proposals submitted to stockholders, such as the election of directors, approval of converting Kindly MD from a Utah corporation to a Delaware corporation, ratification of the independent registered public accounting firm, and potential adjournment of the annual meeting. Notifications of late filing on Form 12b-25 (NT 10-Q) provide context when additional time is needed to complete quarterly reports, including explanations related to the accounting complexity of the merger with Nakamoto.
On Stock Titan, these filings are complemented by AI-powered tools that help summarize lengthy documents and highlight key points, such as new financing obligations, changes in capital structure, or updates on the company’s Bitcoin treasury strategy. Users can quickly locate information about quarterly and annual reporting, material agreements, shareholder votes, and listing status, as well as track how KindlyMD’s integrated healthcare operations and Bitcoin-focused activities are reflected in its regulatory record.
David F. Bailey, listed at 5097 S 900 E Suite 100, Salt Lake City, UT 84117, filed an Initial Statement of Beneficial Ownership (Form 3) for Kindly MD, Inc. (NAKA) on 08/14/2025. The filing identifies Mr. Bailey as both a Director and the Chief Executive Officer and notes the form was filed by one reporting person. The filing expressly states no securities are beneficially owned and includes an Exhibit 24 power of attorney. The report is signed by David Bailey.
Kindly MD, a Utah-based healthcare company focused on hospitals and physicians, has filed Form D for an exempt securities offering under Rule 506(b). The company has successfully completed a $711.7 million offering, with the entire amount already sold to 156 investors.
Key details of the offering include:
- Sales commissions of $20.6 million and finder's fees of $293,400
- Cohen & Company Capital Markets and Anthem Securities LLC serving as brokers, receiving equity fees of 2% and 0.5% respectively of post-closing common stock
- Offering includes equity, debt, and options/warrants
- Connected to a business combination transaction (merger/acquisition)
The company's leadership includes Timothy Pickett as CEO and Director, with other executives Jared Barrera and Adam Cox. The board includes Amy Powell, Christian Robinson, and Gary Seelhorst. The offering was marketed across multiple states including California, New York, Texas, and international markets.
KindlyMD (NASDAQ:NAKA) filed an 8-K announcing the appointment of Andrew Creighton as Chief Commercial Officer of Nakamoto Holdings. The filing indicates this is a Regulation FD disclosure, with the information being furnished rather than filed under Section 18 of the Securities Exchange Act. The company, which is classified as an emerging growth company, made this announcement via press release on June 25, 2025.
Kindly MD has announced a significant merger with Nakamoto Holdings through a complex transaction involving multiple financing components. Key details include:
- Merger agreement where Nakamoto will become a wholly-owned subsidiary of KindlyMD, with Nakamoto shareholders receiving 22.3 million shares at $1.12 per share
- PIPE financing of $511.7 million through subscription agreements at $1.12 per share
- Additional PIPE financing of $51.5 million at $5.00 per share
- Secured convertible debenture of $200 million with Yorkville Advisors
The transaction was approved by written consent of majority stockholders (50.76% voting power) on May 18, 2025, and additional approvals (50.14%) on June 19, 2025. Key governance changes include increasing authorized shares to 10 billion, implementing a classified board structure, and establishing exclusive forum provisions in Utah courts. The company will also adopt a new 2025 Equity Incentive Plan and issue up to 600 million shares under a Marketing Agreement with BTC.
Kindly MD has announced a significant private placement (PIPE Financing) of up to 10,300,000 shares of common stock at $5.00 per share, targeting an aggregate amount of $51.5 million. This financing is connected to a previously announced merger with Nakamoto Holdings.
Key details of the transaction include:
- The PIPE Financing will close concurrently with the merger completion
- Proceeds will be used to purchase Bitcoin and for working capital purposes
- Company will file registration statement within 30 days post-closing
- Majority shareholders approved the subscription agreements on June 19, 2025
The company's stock (NAKA) last traded at $13.94 per share, with tradeable warrants (NAKAW) at $8.43. The filing also covers 2,059,811 shares issuable upon exercise of previously issued warrants and 82,310 shares of common stock for resale by selling stockholders.
Kindly MD has announced a significant private placement (PIPE Financing) worth $51.5 million, approved by its board on June 19, 2025. The company will issue up to 10,300,000 shares of common stock at $5.00 per share to certain investors.
Key details of the PIPE Financing:
- Proceeds will be used to purchase Bitcoin and for working capital purposes
- Closing is contingent upon completion of previously announced merger with Nakamoto Holdings
- Company must file registration statement within 30 days post-closing
- Registration must be effective within 60-90 days of filing
Additionally, majority shareholders approved the subscription agreements and the issuance of over 20% of company's common stock to comply with Nasdaq listing rules. The securities will be issued under Section 4(a)(2) of the Securities Act exemption. The merger and PIPE financing must close by November 14, 2025, or the agreements may be terminated.